DeutschNewstral
Article
Iindystar.com on 2021-05-28 16:53
Eli Lilly faces federal investigation at New Jersey plant that produces COVID therapy
Related news
FDA grants emergency authorization to new Eli Lilly antibody therapy for use against omicronstaradvertiser.com- IEli Lilly to buy gene therapy biotech company in a deal valued at $1 billionindystar.com
Eli Lilly ends drug development, stock plungesUSA today- MEli Lilly therapy with donanemab slowed illness developmentmvtelegraph.com
- HEli Lilly to Trim Workforce by Nearly 9 Percenthamodia.com
- IEli Lilly to require COVID vaccine for employees. Here's where other big employers stand.indystar.com
Eli Lillymichronicleonline.com
Eli Lilly verabschiedet sich vom TiergesundheitsgeschäftReuters
Eli Lilly ends development of insulin peglisproelkharttruth.com
Eli Lilly blocked warnings about U.S. drug factory, insider allegesreuters.com- IEli Lilly will reopen with 25% of employees on June 1 and fully reopen July 12indystar.com
Eli Lilly Acquiring Cancer Therapy Developer For $1.4 Billion—A Nearly 90% PremiumForbes- BEli Lilly Signs $210M Deal With U.S. for Covid-19 Antibody Therapybarrons.com
Eli Lilly says experimental drug slows Alzheimer’s worseningHartford Courant
Eli Lilly applies for FDA approval on Alzheimer’s drugnwaonline.com
Eli Lilly says experimental drug slows Alzheimer's worseningtimesfreepress.com- Eli Lilly Covid-19 Antibody Treatment Granted Emergency FDA AuthorizationForbes
Eli Lilly cutting prices on some insulin productsArkansas Online